We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




MEDICA Health IT Forum 2023 to Highlight General Digitalization Trends

By LabMedica International staff writers
Posted on 13 Oct 2023

This year, the MEDICA HEALTH IT FORUM will once again be a part of the renowned international medical trade fair MEDICA (Düsseldorf, Germany) scheduled for 13-16 November 2023. More...

The MEDICA HEALTH IT FORUM is a platform for innovations where attendees can experience top-class talks and sessions on the way to data-driven healthcare. In addition, there will be topic-related exhibits from leading universities and research institutions in the adjoining exhibition area, providing a comprehensive and tangible picture of digitally-optimized medicine.

The MEDICA HEALTH IT FORUM 2023 will bundle expertise and the latest developments and the pioneers of the industry will themselves be present. The forum 2023 will include expert panels with a keynote, followed by a series of statements and a panel discussion, as well as Q&A, a series of complementary tech talks, and open mic for exhibitor lectures & demonstrations. The complete program of the MEDICA HEALTH IT FORUM is as follows:

Monday, 13 November 2023

  • Drug discovery with AI
  • Quantum computing
  • Circularity in healthcare
  • Gamification
  • Female doctorpreneurship
  • Open mic

Tuesday, 14 November 2023

  • Predictive analytics
  • Healthcare metaverse
  • Chat GPT & Co.
  • Smart textiles
  • TikTok, Insta & Co. - Engaging, learning and networking on social media platforms
  • Green Hospital
  • Open mic

Wednesday, 15 November 2023

  • Data spaces & platforms
  • Consumer health
  • Safe AI
  • Circadian health
  • Digital empowerment
  • Open mic

Thursday, 16 November 2023

  • Digital mental health
  • Automation in healthcare / RPA
  • Health tech for the elderly
  • Medical education & digitization
  • Nutrition
  • Open mic

Related Links:
MEDICA


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
HPV Test
Allplex HPV28 Detection
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
image Credit: iStock

Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer

Outcomes after resection for lung squamous cell carcinoma (SqCC) vary substantially, and the uneven benefit of adjuvant chemotherapy complicates postsurgical treatment decisions. Pathologic markers that... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.